Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is an emerging risk factor and therapeutic target for cardiovascular disease. The activity and mass of this enzyme are heritable traits, but major genetic determinants have not been explored in a systematic, genome-wide fashion. We carried out a...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-04-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC2861686?pdf=render |